Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Human Immunology|July 19, 2022
Preclinical rationale and current pathways to support the first human clinical trials in cardiac xenotransplantationMuhammad M Mohiuddin, Avneesh K Singh, Corbin E Goerlich
Nature Cardiovascular Research|March 10, 2023
The immunobiology and clinical use of genetically engineered porcine hearts for cardiac xenotransplantationCorbin E Goerlich, Avneesh K Singh, Bartley P Griffith, et al.
Xenotransplantation|April 14, 2012
Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune responseAvneesh K Singh, Caleb N Seavey, Keith A Horvath, et al.
Xenotransplantation|September 20, 2022
The road to the first FDA-approved genetically engineered pig heart transplantation into humanAvneesh K Singh, Bartley P Griffith, Corbin E Goerlich, et al.
Transplantation|December 30, 2022
CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for TransplantationAvneesh K Singh, Corbin E Goerlich, Tianshu Zhang, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 28, 2021
The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donorsCorbin E Goerlich, Bartley Griffith, Peter Hanna, et al.
Clinical Transplantation|June 30, 2018
Consideration of appropriate clinical applications for cardiac xenotransplantationJoshua L Chan, Justin G Miller, Avneesh K Singh, et al.
Xenotransplantation|August 3, 2007
Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation modelCynthia M Porter, Judith A Horvath-Arcidiacono, Avneesh K Singh, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 8, 2014
Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantationMuhammad M Mohiuddin, Avneesh K Singh, Philip C Corcoran, et al.
Pageof 13